Cite
Evodiamine decreased the systemic exposure of pravastatin in non-alcoholic steatohepatitis rats due to the up-regulation of hepatic OATPs.
MLA
Ruifeng Liang, et al. “Evodiamine Decreased the Systemic Exposure of Pravastatin in Non-Alcoholic Steatohepatitis Rats Due to the up-Regulation of Hepatic OATPs.” Pharmaceutical Biology, vol. 60, no. 1, Dec. 2022, pp. 359–73. EBSCOhost, https://doi.org/10.1080/13880209.2022.2036767.
APA
Ruifeng Liang, Wenjing Ge, Bingjie Li, Weifeng Cui, Xiaofan Ma, Yuying Pan, & Gengsheng Li. (2022). Evodiamine decreased the systemic exposure of pravastatin in non-alcoholic steatohepatitis rats due to the up-regulation of hepatic OATPs. Pharmaceutical Biology, 60(1), 359–373. https://doi.org/10.1080/13880209.2022.2036767
Chicago
Ruifeng Liang, Wenjing Ge, Bingjie Li, Weifeng Cui, Xiaofan Ma, Yuying Pan, and Gengsheng Li. 2022. “Evodiamine Decreased the Systemic Exposure of Pravastatin in Non-Alcoholic Steatohepatitis Rats Due to the up-Regulation of Hepatic OATPs.” Pharmaceutical Biology 60 (1): 359–73. doi:10.1080/13880209.2022.2036767.